Cross-reactivity of the CEDIA buprenorphine assay with opiates: An Austrian phenomenon?

International Journal of Legal Medicine

Volumn 119, Issue 6, 2005, Pages 378-381

  Pavlic, M ^a   Libiseller, K ^a   Grubwieser, P ^a   Rabl, W ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Buprenorphine; CEDIA; Cross reactivity; Opiate maintenance therapy; Opiates

Indexed keywords

BUPRENORPHINE; CODEINE; DIHYDROCODEINE; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; OPIATE;

ARTICLE; AUSTRIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; DRUG SCREENING; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAINTENANCE THERAPY; PRIORITY JOURNAL; URINALYSIS;

AUSTRIA; BUPRENORPHINE; CROSS REACTIONS; HUMANS; IMMUNOASSAY; LINEAR MODELS; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; RETROSPECTIVE STUDIES;

EID: 27744591249     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-005-0544-x     Document Type: Article

References (21)

1. Cone EJ, Preston KL (2002) Toxicologic aspects of heroin substitution treatment. Ther Drug Monit 24:193-198
2. Dole VP, Nyswander M (1965) A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA 193:646-650
3. Gschwend P, Rehm J, Blattler R et al (2004) Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland - Swiss national cohort study. Eur Addict Res 10:41-48
4. Der Schweizerische Bundesrat (1999) Verordnung über die ärztliche Verschreibung von Heroin. Verordnung 812.121.6, Betäubungsmittelgesetz 1951
5. van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM (2003) Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 327:310
6. Das bundesdeutsche Modellprojekt zur heroingestützten Behandlung Opiatabhängiger (2002) http://heroinstudie.de/forschungsdesign_kurzfassung. pdf
7. Walsh SL, Preston KL, Bigelow GE, Stitzer ML (1995) Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther 274:361-372
8. Jasinski DR, Pevnick JS, Griffith JD (1978) Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry 35:501-516
9. Bickel WK, Stitzer ML, Bigelow GE, Liebson LA, Jasinski DR, Johnson RE (1988) Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. J Pharmacol Exp Ther 247:47-53
10. Giacomuzzi SM, Riemer Y, Ertl M, Kemmler G, Rossler H, Hinterhuber H, Kurz M (2003) Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment. Addiction 98:693-702
11. Ling W, Charuvastra C, Collins JF et al (1998) Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 93:475-486
12. Mattick RP, Ali R, White JM, O'Brien S, Wolk S, Danz C (2003) Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 98:441-452
13. West SL, O'Neal KK, Graham CW (2000) A meta-analysis comparing the effectiveness of buprenorphine and methadone. J Subst Abuse 12:405-414
14. Petitjean S, Stohler R, Deglon JJ, Livoti S, Waldvogel D, Uehlinger C, Ladewig D (2001) Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug Alcohol Depend 62:97-104
15. Uehlinger C, Deglon J, Livoti S, Petitjean S, Waldvogel D, Ladewig D (1998) Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study. Eur Addict Res 4(Suppl 1):13-18
16. Eder H, Fischer G, Gombas W, Jagsch R, Stuhlinger G, Kasper S (1998) Comparison of buprenorphine and methadone maintenance in opiate addicts. Eur Addict Res 4(Suppl 1):3-7
17. Fischer G, Gombas W, Eder H et al (1999) Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 94:1337-1347
18. Bundesministerium für Soziale Sicherheit und Generationen (1998) Erlass "Orale Substitutionsbehandlung von Suchtkranken"
19. Kraigher D, Ortner R, Eder H, Schindler S, Fischer G (2002) Slow-release morphine hydrochloride for maintenance therapy of opioid dependence. Wien Klin Wochenschr 114:904-910
20. Baselt RC (2002) Morphine. In: Basel RC (ed) Disposition of toxic drugs and chemicals in man. Biomedical Publications, Foster City, pp 720-724
21. Albers C, Kohler H, Lehr M, Brinkmann B, Beike J (2004) Development of a psilocin immunoassay for serum and blood samples. Int J Legal Med 118:326-331